RM新时代app下载

    1. <nav id="2a3lq"><ins id="2a3lq"><video id="2a3lq"></video></ins></nav>

      <progress id="2a3lq"></progress>
      中慈保健品科技開發有限公司
      R&D team
      E-commerce, micro-business, direct sales, fair sales, channel brand health food OEM/ODM professional processing manufacturer
      ZHONGCI Health Products Research Institute
      It has a research and development team with doctoral and master's degrees in bioengineering, food engineering and other fields. It has joint research with Chinese Academy of Sciences, Changchun University, Jiangnan University and South China University of Technology, and established China Construction (Guangzhou) Biomedical Research in Luogang, Guangzhou. College, familiar with molecular biology, nutrition, biochemistry, bioinformatics and other scientific and technological fields.
      Li Ronghe
      Core Strategist
      Peptide inventor scientist, national-level scientific research expert with outstanding contributions, winner of the national "May 1st Labor Medal", director of Changchun University Science and Technology Development Center, professor of Changchun University, Zhongci small molecule active peptide was invented by Professor Li Ronghe and his research team.
      Zhang Jiaheng
      Strategic cooperation expert
      Professor of the School of Materials Science and Engineering, Harbin Institute of Technology (Shenzhen), young top-notch talents of Harbin Institute of Technology, and expert of the national "God-man Program" youth project, developed "Natural Ionic Liquid (Salt)" and "Natural Deep Co-Fusion Liquid", etc. technology.
      Xu Wei
      Chief R&D Director
      He has worked in many pharmaceutical companies such as Anshi Pharmaceuticals in the United States, under the tutelage of Dr. Zhang Hongwei from CSBio, engaged in the research of peptide drugs. Completed drug peptides successively: thymus five belly, somatostatin, octreotide, salmon calcitonin. Terlipressin, Desmopressin, Quqingrelin, etc. The whole process from raw material to preparation. Completed the R&D and production of recombinant streptase for injection of Class I new drugs, recombinant streptokinase (r-SK), a new genetic engineering drug, is the first Class I new biotechnology drug with independent intellectual property rights in my country, and was included in the National Torch 2000 planned project, and was selected as a major national pharmaceutical innovation project.
      Research Base
      The national pharmaceutical-grade standard production factory uses the standard of producing pharmaceuticals to produce large health food. The production base has passed the GMP quality and safety management system certification, HACCP food safety assurance system certification, and conducts quality monitoring according to the ISO22000 food safety quality management system standard. The factory has more than 100,000 dust-free clean workshops and imported fully automated machines, dozens of fully automated production lines, fully automatic packaging lines and other advanced equipment, professional testing to ensure product quality and safety.
      RM新时代app下载

      1. <nav id="2a3lq"><ins id="2a3lq"><video id="2a3lq"></video></ins></nav>

        <progress id="2a3lq"></progress>
        RM新时代手机版下载 RM新时代APP官网 RM新时代app下载

        1. <nav id="2a3lq"><ins id="2a3lq"><video id="2a3lq"></video></ins></nav>

          <progress id="2a3lq"></progress>
          rm理财 新时代官网 RM新时代反波胆平台有限公司 RM新时代赚钱项目 rm新时代正规吗